Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, K.-S. | - |
dc.contributor.author | Kwon, Y.-S. | - |
dc.contributor.author | Kim, S. | - |
dc.contributor.author | Moon, D.-S. | - |
dc.contributor.author | Kim, H.J. | - |
dc.contributor.author | Nam, K.-S. | - |
dc.date.accessioned | 2021-08-03T04:31:47Z | - |
dc.date.available | 2021-08-03T04:31:47Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 0753-3322 | - |
dc.identifier.issn | 1950-6007 | - |
dc.identifier.uri | https://www.kriso.re.kr/sciwatch/handle/2021.sw.kriso/635 | - |
dc.description.abstract | Several previous studies have shown the benefits of deep sea water (DSW) in lipid metabolism. However, the effects of DSW on cellular cholesterol accumulation and synthesis induced by high glucose or free fatty acid plus high glucose [4.5?g/L] (FFA/glucose) have not been fully elucidated to date. Herein, we showed the effects of mineral-balanced DSW [magnesium (Mg):calcium (Ca)?=?3:1] (MB-DSW) on cholesterol metabolism induced by high glucose or FFA/glucose in HepG2 hepatic cells. Moreover, the effects of high ratio Mg DSW [Mg:Ca?=?40:1] (Mg40) were also investigated. MB-DSW and Mg40 prevented the increase of cellular total cholesterol content in high glucose- or FFA/glucose-treated HepG2 hepatic cells. Furthermore, the inhibition by MB-DSW was closely related to the down-regulation of 3-hydroxy-3-methylglutatryl-CoA reductase (HMGCR) expression and an increase in the AMP-activated protein kinase (AMPK) phosphorylation, leading to decreased cholesterol synthesis in both high glucose- and FFA/glucose-treated conditions. However, this effect was not seen in case of Mg40. In addition, both MB-DSW and Mg40 induced the low-density lipoprotein receptor (LDLR) and diminished the proprotein convertase subtilisin/kexin type 9 (PCSK9) transcriptions in high glucose-treated HepG2 hepatic cells. This result demonstrates that the hypocholesterolemic effects of MB-DSW and Mg40 are mediated with LDL-c clearance through increases of LDLR and its transcription factors, such as peroxisome proliferator-activated receptor-α (PPAR-α), sterol regulatory element-binding protein (SREBP)-1a, and SREBP-2, mRNA synthesis and suppression of PCSK9 transcription. Moreover, apolipoprotein (Apo) A1 transcription was enhanced by MB-DSW and Mg40 without decreasing the expression of Apo B in high glucose-treated HepG2 hepatic cells. However, ApoA1 protein expression was not changed. Taken together, the present investigation suggests that DSW may prevent the high glucose- or FFA/glucose-induced increase of cellular cholesterol levels by inducing LDLR and ApoA1 transcriptions and inhibiting PCSK9 mRNA expression in HepG2 hepatic cells. Additionally, the ratio of Mg in DSW is an important factor that determines whether HMGCR expression and/or AMPK phosphorylation participate in the hypocholesterolemic effects of DSW. ? 2016 Elsevier Masson SAS | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier Masson SAS | - |
dc.title | Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells | - |
dc.type | Article | - |
dc.publisher.location | 프랑스 | - |
dc.identifier.doi | 10.1016/j.biopha.2016.12.046 | - |
dc.identifier.scopusid | 2-s2.0-85006741677 | - |
dc.identifier.bibliographicCitation | Biomedicine and Pharmacotherapy, v.86, pp 405 - 413 | - |
dc.citation.title | Biomedicine and Pharmacotherapy | - |
dc.citation.volume | 86 | - |
dc.citation.startPage | 405 | - |
dc.citation.endPage | 413 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | Transcription Factors | - |
dc.subject.keywordPlus | 3 hydroxy 3 methylglutatryl coa reductase | - |
dc.subject.keywordPlus | acyl coenzyme A desaturase | - |
dc.subject.keywordPlus | apolipoprotein A1 | - |
dc.subject.keywordPlus | apolipoprotein B | - |
dc.subject.keywordPlus | calcium | - |
dc.subject.keywordPlus | carnitine palmitoyltransferase I | - |
dc.subject.keywordPlus | fatty acid synthase | - |
dc.subject.keywordPlus | glucose | - |
dc.subject.keywordPlus | hydroxymethylglutaryl coenzyme A reductase kinase | - |
dc.subject.keywordPlus | hypocholesterolemic agent | - |
dc.subject.keywordPlus | low density lipoprotein cholesterol | - |
dc.subject.keywordPlus | low density lipoprotein receptor | - |
dc.subject.keywordPlus | magnesium | - |
dc.subject.keywordPlus | mineral | - |
dc.subject.keywordPlus | mineral balanced deep sea water | - |
dc.subject.keywordPlus | oxidoreductase | - |
dc.subject.keywordPlus | peroxisome proliferator activated receptor alpha | - |
dc.subject.keywordPlus | proprotein convertase 9 | - |
dc.subject.keywordPlus | sea water | - |
dc.subject.keywordPlus | sterol regulatory element binding protein 1a | - |
dc.subject.keywordPlus | sterol regulatory element binding protein 2 | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | cholesterol | - |
dc.subject.keywordPlus | glucose | - |
dc.subject.keywordPlus | HMGCR protein, human | - |
dc.subject.keywordPlus | hydroxymethylglutaryl coenzyme A reductase | - |
dc.subject.keywordPlus | hydroxymethylglutaryl coenzyme A reductase kinase | - |
dc.subject.keywordPlus | hypocholesterolemic agent | - |
dc.subject.keywordPlus | low density lipoprotein | - |
dc.subject.keywordPlus | low density lipoprotein receptor | - |
dc.subject.keywordPlus | messenger RNA | - |
dc.subject.keywordPlus | mineral | - |
dc.subject.keywordPlus | mineral water | - |
dc.subject.keywordPlus | proprotein convertase 9 | - |
dc.subject.keywordPlus | sea water | - |
dc.subject.keywordPlus | transcription factor | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | cell proliferation | - |
dc.subject.keywordPlus | cholesterol blood level | - |
dc.subject.keywordPlus | cholesterol metabolism | - |
dc.subject.keywordPlus | cholesterol synthesis | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | deep sea | - |
dc.subject.keywordPlus | down regulation | - |
dc.subject.keywordPlus | drug activity | - |
dc.subject.keywordPlus | drug mechanism | - |
dc.subject.keywordPlus | energy expenditure | - |
dc.subject.keywordPlus | enzyme activation | - |
dc.subject.keywordPlus | enzyme phosphorylation | - |
dc.subject.keywordPlus | gene expression | - |
dc.subject.keywordPlus | gene repression | - |
dc.subject.keywordPlus | genetic transcription | - |
dc.subject.keywordPlus | Hep-G2 cell line | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | human cell | - |
dc.subject.keywordPlus | hypocholesterolemic activity | - |
dc.subject.keywordPlus | hypocholesterolemic effect | - |
dc.subject.keywordPlus | lipid metabolism | - |
dc.subject.keywordPlus | messenger RNA synthesis | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | protein expression | - |
dc.subject.keywordPlus | drug effects | - |
dc.subject.keywordPlus | Hep-G2 cell line | - |
dc.subject.keywordPlus | metabolism | - |
dc.subject.keywordPlus | phosphorylation | - |
dc.subject.keywordPlus | tumor cell line | - |
dc.subject.keywordPlus | AMP-Activated Protein Kinases | - |
dc.subject.keywordPlus | Anticholesteremic Agents | - |
dc.subject.keywordPlus | Cell Line, Tumor | - |
dc.subject.keywordPlus | Cholesterol | - |
dc.subject.keywordPlus | Down-Regulation | - |
dc.subject.keywordPlus | Glucose | - |
dc.subject.keywordPlus | Hep G2 Cells | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Hydroxymethylglutaryl CoA Reductases | - |
dc.subject.keywordPlus | Lipoproteins, LDL | - |
dc.subject.keywordPlus | Mineral Waters | - |
dc.subject.keywordPlus | Minerals | - |
dc.subject.keywordPlus | Phosphorylation | - |
dc.subject.keywordPlus | Proprotein Convertase 9 | - |
dc.subject.keywordPlus | Receptors, LDL | - |
dc.subject.keywordPlus | RNA, Messenger | - |
dc.subject.keywordPlus | Seawater | - |
dc.subject.keywordAuthor | AMPK | - |
dc.subject.keywordAuthor | HMG-CoA reductase | - |
dc.subject.keywordAuthor | Hypercholesterolemia | - |
dc.subject.keywordAuthor | Lipid metabolism | - |
dc.subject.keywordAuthor | Mineral-balanced deep sea water | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(34103) 대전광역시 유성구 유성대로1312번길 32042-866-3114
COPYRIGHT 2021 BY KOREA RESEARCH INSTITUTE OF SHIPS & OCEAN ENGINEERING. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.